J&J, Bristol Myers Squibb lose Medicare drug price talks challenges

J&J, Bristol Myers Squibb lose Medicare drug price talks challenges

Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson and Bristol Myers Squibb‘s legal challenges to the Biden administration’s Medicare drug price negotiations, ruling that the program is constitutional.  The decision is another win for the Biden administration in a bitter legal fight with several … Read more

ARK says it’s a unique time to invest

ARK says it’s a unique time to invest

ARK Invest’s chief futurist lists five groups that should give tech investors an edge. According to Brett Winton, robotics, artificial intelligence, multi-omics sequencing, public blockchain and energy storage are key areas because they’re all entering the marketplace at the same time. “We believe that this is a unique time in technological economic history,” he told … Read more

CVS Omnicare pharmacy in Vegas is first to join new pharmacy union

CVS Omnicare pharmacy in Vegas is first to join new pharmacy union

The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on February 7, 2024. Patrick T. Fallon | AFP | Getty Images A CVS in Las Vegas has become the first location to join a new national pharmacy union, a milestone as organizers try to help … Read more

FDA approves Pfizer gene therapy Beqvez for treatment of hemophilia B

FDA approves Pfizer gene therapy Beqvez for treatment of hemophilia B

Pavlo Gonchar | Lightrocket | Getty Images The Food and Drug Administration on Friday approved Pfizer‘s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.  The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B … Read more

Bristol Myers Squibb (BMY) earnings Q1 2024

Bristol Myers Squibb (BMY) earnings Q1 2024

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023.  Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its blockbuster blood thinner Eliquis and several new drugs posted sales growth. But the pharmaceutical company … Read more

Merck (MRK) earnings Q1 2024

Merck (MRK) earnings Q1 2024

Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products. The pharmaceutical giant also raised and narrowed its … Read more

Walgreens launches cell, gene therapies in service expansion

Walgreens launches cell, gene therapies in service expansion

A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said it will start to work directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader expansion of its specialty … Read more

Biogen (BIIB) earnings Q1 2024

Biogen (BIIB) earnings Q1 2024

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported first-quarter profit that topped estimates as the company’s cost-cutting efforts took hold and sales of its closely watched Alzheimer’s drug, Leqembi, came in higher than expected. Biogen and … Read more

3.6 million Medicare patients could get heart health coverage

3.6 million Medicare patients could get heart health coverage

More than 3 million people with Medicare could be eligible for coverage of Wegovy now that the blockbuster weight loss drug is also approved in the U.S. for heart health, according to an analysis released Wednesday by health policy research organization KFF. But some eligible beneficiaries could still face out-of-pocket costs for the highly popular … Read more

Swiss pharma giant Roche’s first-quarter sales edge higher as its emerges from post-Covid-19 slump

Swiss pharma giant Roche’s first-quarter sales edge higher as its emerges from post-Covid-19 slump

A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024. Bloomberg | Getty Images Swiss pharmaceutical company Roche on Wednesday reported a modest uptick in first-quarter sales, even as waning demand for its Covid-19 products continued to weigh on the company. Sales were up 2% at constant exchange rates, … Read more